Global Diagnostic Imaging Market Expected to Reach $33.2 Billion by 2031

The global diagnostic imaging market is projected to grow significantly over the next five years, reaching $33.2 billion by 2031, according to a new report by Wissen Research. The market is expected to expand at a compound annual growth rate (CAGR) of 4.6% from 2026 to 2031, driven by rising demand for early disease detection and the increasing adoption of AI-enabled imaging technologies.

The report highlights several key factors driving the market's growth. Chronic disease prevalence and an expanding geriatric population are increasing the need for more precise and earlier disease detection. AI-assisted imaging, 3D/4D visualization, and portable imaging devices are enhancing diagnostic accuracy and streamlining radiology workflows. These advancements are extending imaging access across various healthcare settings, including hospitals, outpatient clinics, emergency departments, and rural healthcare facilities.

One of the most significant shifts in diagnostic imaging is the integration of deep learning reconstruction (DLR) algorithms directly into image acquisition pipelines. This technology is enabling real-time noise reduction during data capture, improving diagnostic precision and reducing scan times. For instance, GE HealthCare's Sonic DL sequence now allows complex multi-sequence brain and joint MRI protocols to be completed in under 15 minutes, significantly increasing daily throughput per scanner without requiring new capital equipment.

Cloud-native picture archiving and communication systems (PACS) and teleradiology platforms are also transforming the landscape. These platforms are replacing on-premise image archives, enabling remote reading across multi-site networks and reducing reporting turnaround times. Photon-counting computed tomography (CT) and hybrid imaging systems are pushing resolution higher while lowering radiation dose, supporting earlier detection in oncology, cardiology, and neurology.

The market is segmented by modality, technology, portability, architecture, application, end user, and region. X-ray systems led the market by modality in 2025, supported by the highest global procedure volumes and lower installation and infrastructure requirements. 2D imaging held the largest share by technology type, driven by faster acquisition and turnaround times and the fact that most AI triage algorithms were built around standard 2D radiography and ultrasound workflows.

North America led the diagnostic imaging market in 2025, underpinned by advanced healthcare infrastructure, high imaging procedure volumes, favorable reimbursement for advanced modalities, and sustained hospital investment in premium imaging technology. The aging population and the formation of large health networks and group purchasing organizations continue to support long-term equipment and service contracts.

Asia-Pacific is the fastest-growing region, driven by healthcare infrastructure expansion, rising healthcare expenditure, and growing adoption of AI-enabled and portable imaging across urban and underserved areas. Government investment in healthcare modernization and the growth of private hospitals and imaging centers are accelerating adoption, while AI-enabled and portable systems are extending diagnostic capability into underserved areas.

However, the market faces several challenges. Reimbursement compression is emerging as the sector's most pressing operational constraint. The Centers for Medicare & Medicaid Services introduced an efficiency adjustment in the 2026 Medicare Physician Fee Schedule that permanently reduces work relative value units by 2.5% across roughly 7,700 diagnostic and procedural codes. New combined head and neck CTA codes have produced global payment reductions of up to 30.8%. This has led to a growing misalignment between what providers invest in premium scanners and what public payers reimburse, pushing many networks to extend equipment life cycles rather than upgrade.

High acquisition and maintenance costs for MRI and CT systems remain a barrier for community hospitals and providers in developing markets. A persistent shortage of qualified radiologists is contributing to reporting backlogs, while the shift to cloud-based imaging raises data security and cybersecurity considerations for healthcare providers.

Leading companies in the diagnostic imaging market, including GE HealthCare, Siemens Healthineers, Philips, Canon Medical Systems, and Fujifilm Holdings, are focusing on embedding AI into imaging platforms, expanding cloud and enterprise imaging capabilities, and broadening portable and point-of-care portfolios. Recent strategic developments include the introduction of next-generation MRI technologies and AI-based workflow solutions by GE HealthCare, an integrated workflow solution for CT-guided percutaneous coronary interventions by Siemens Healthineers, and the launch of the ARIETTA Deep Insight x ultrasound platform by Fujifilm Holdings.

In conclusion, the diagnostic imaging market is poised for steady growth, driven by technological advancements and increasing demand for early disease detection. However, providers must navigate challenges such as reimbursement compression and high equipment costs to fully realize the benefits of these innovations.